&Partners’s Eli Lilly & Co Position
Does &Partners own Eli Lilly & Co (LLY)? Yes — 171.7K shares worth $158M (+0.78% of its 13F portfolio) as of Q1 2026, up from 160.6K shares the prior filed quarter.
Position Value
$158M
Q1 2026
Shares
171.7K
% of Portfolio
+0.78%
Quarters Held
16
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 171.7K | $158M | +0.78% |
| Q4 2025 | 160.6K | $173M | +0.90% |
| Q3 2025 | 123.2K | $94M | +0.60% |
| Q2 2025 | 119.3K | $93M | +0.71% |
| Q1 2025 | 92.5K | $76M | +0.81% |
| Q4 2024 | 67.1K | $53M | +0.63% |
| Q3 2024 | 39.3K | $35M | +0.67% |
| Q2 2024 | 16.7K | $15M | +0.66% |
| Q1 2024 | 2.4K | $2M | +0.26% |
| Q4 2023 | 5.0K | $3M | +0.71% |
| Q3 2023 | 1.0K | $557,541 | +0.26% |
| Q2 2023 | 811 | $380,343 | +0.17% |
| Q1 2023 | 676 | $232,152 | +0.11% |
| Q4 2022 | 673 | $246,210 | +0.12% |
| Q3 2022 | 991 | $320,000 | +0.19% |
| Q2 2022 | 901 | $292,000 | +0.17% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See &Partners’s full portfolio or all institutional holders of LLY.